For Wegovy, it is 28 days

Accreditations to Look For PCAB (Pharmacy Compounding Accreditation Board): Voluntary accreditation program Comprehensive quality standards Third-party verification of practices Demonstrates commitment to quality ACHC (Accreditation Commission for Health Care): Accredits various healthcare organizations Includes pharmacy accreditation Third-party quality verification State licenses: Required for legal operation Can verify with state pharmacy board Check for any disciplinary actions Red Flags to Watch For Pricing concerns: Prices significantly below market (below $100/month suggests corners being cut) Prices that seem too good to be true usually are Regulatory concerns: No prescription required Shipping from overseas Unable to provide facility information No verifiable pharmacy license Quality concerns: No testing mentioned or available Cant provide Certificates of Analysis Vague about sourcing No beyond-use dating Transparency concerns: Unwilling to answer questions No physical address No pharmacist available Anonymous or unclear ownership What Good Quality Looks Like Reputable compounders typically: Provide clear information about their facility Source from verified suppliers Test finished products Provide Certificates of Analysis on request Have verifiable licenses and registrations Employ licensed pharmacists Follow USP standards (and cGMP for 503B) Have clear beyond-use dating Store and ship products properly The Semaglutide Sodium Concern Recent FDA communications have raised concerns about certain compounded products

Research-grade vials commonly come in 2 mg, 5 mg, and 10 mg sizes
Medical consumable supplies available alongside pharmacy products Product info sheets, dosing guides, and marketing materials connected to ordering Easier enterprise ordering Dosing guides supported by clinical pharmacists Team of clinical pharmacists available for provider and account support Single source for reporting, order tracking, order history, and reordering Ready to Get Started
More Wegovy adult patients compared with placebo had maximum changes from baseline of 10 to 19 bpm (41% versus 34%) and 20 bpm or more (26% versus 16%)
doi: 10.1007/s13311-021-01088-5 91 da SilvaEMYariwakeVYAlvesRWde AraujoDRAndrade-OliveiraV